Dr. Annette Langer-Gould headshot

Annette Langer-Gould, MD, PhD, MS

Affiliated Investigator


Los Angeles Medical Center




Dr. Annette Langer-Gould is the regional lead for Clinical and Translational Neuroscience for the Southern California Permanente Medical Group and a practicing multiple sclerosis specialist at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould leads a team that develops, implements, and evaluates programs to provide high-quality, affordable care for individuals with MS and other neurologic diseases.

Dr. Langer-Gould has been studying different aspects of MS susceptibility and prognosis for over 15 years. Her epidemiologic research focuses on how the interplay between genotype and modifiable factors such as race/ethnicity, vitamin D, and sun exposure determines MS susceptibility and prognosis. In collaboration with the Swedish MS Registry, she is also studying the comparative effectiveness of rituximab and other MS treatments in a trial funded by the Patient-Centered Outcomes Research Institute. Dr. Langer-Gould currently serves as a voting member on the California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review.

Areas of Focus

  • Multiple sclerosis susceptibility, prognosis and treatment
  • Migraine care models
  • Comparative effectiveness and safety of treatments
  • Alzheimer's disease care models


University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
PhD, Epidemiology
Stanford University
Stanford, California
MS, Clinical Epidemiology
Stanford University
Stanford, California

Honors and Awards

Southern California Permanente Medical Group Clinical Trials Access Merit Award
Mentored Clinical Research Career Development Award (K23), National Institutes of Health, National Institute of Neurological Disorders and Stroke
Wadsworth Foundation Young Investigator’s Award